About the Company
gossamer bio is a san diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. founded by the former receptos executive team, gossamer bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $GOSS News
Gossamer Bio Posts Narrower Loss In Q4 - Quick Facts
(RTTNews) - Gossamer Bio, Inc. (GOSS) posted a fourth quarter net loss of $48.1 million, or $0.21 per share, compared to a net loss of $55.8 million, or $0.59 per share, a year ago. On average, eight ...
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...
Gossamer Bio Earns ‘Buy’ Rating from Analyst Citing Progress in Seralutinib Trials and Strategic Market Expansion
Wedbush analyst Andreas Argyrides has reiterated their bullish stance on GOSS stock, giving a Buy rating yesterday. Andreas Argyrides has ...
Should You Buy Gossamer Bio (GOSS) After Golden Cross?
Gossamer Bio, Inc. (GOSS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GOSS's 50-day simple moving average broke out above its ...
Gossamer Bio Inc GOSS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Gossamer Bio: Q4 Earnings Snapshot
SAN DIEGO — SAN DIEGO — Gossamer Bio Inc. (GOSS) on Tuesday reported a loss of $48.1 million in its fourth quarter. The San Diego-based company said it had a loss of 21 cents per share. The results ...
Gossamer Bio, Inc. (GOSS)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Gossamer Bio: Q4 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Gossamer Bio Inc. (GOSS) on Tuesday reported a loss of $48.1 million in its fourth quarter. The San Diego-based company said it had a loss of 21 cents per share.
Gossamer Bio Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...